Hero mask

Medicine that listens

Reimagining pharmaceutical injectable solutions to solve frontline healthcare challenges

Care-led innovation

Serovia, meaning ‘care-led innovation’, was established in 2025 to address the unmet needs of all stakeholders across the hospital value chain. Our goal? Develop impactful pharmaceutical injectable solutions that genuinely ease pressure, save time, and improve safety for real-world users.

 

We look to achieve this by listening first, so that every product we develop is designed to deliver tangible operational and clinical benefits. Combining commercial acumen with scientific and clinical insight, we bring value-added sterile injectable solutions to life, targeting complex, first-to-market, and 505(b)(2) opportunities, including ready-to-use IV bags manufactured in the US.

Backed by Karuna Health Group

Serovia is stewarded by Karuna Health Group, a global healthcare holding entity with investments across leading pharmaceuticals businesses. With 20+ manufacturing sites and a presence in 100+ countries, Karuna drives an ‘in-market for market’ strategy worldwide.

30+

years’ experience 

35+

facilities and R&D 

100+

countries

7000+

employees 

$1B+

revenue  

$3.9B+

value

Discover what sets us apart

Our unique process of understanding, testing, refining, and iterating turns real-world insights into smarter solutions that go further. We listen first to effectively validate and drive pragmatic, value-added solutions with pharmacists, clinicians, patients, partners, key opinion leaders (KOLs), and industry experts.

Together, we aim to make healthcare safer, easier, and more effective for everyone giving and receiving care.

Follow us on LinkedIn

Scaling ideas into meaningful products

Serovia is set to make a lasting impact in the specialty injectables space.

3 decades

of sterile injectables experience  

Proprietary R&D 

with in-house capabilities

Dedicated US specialty division 

and deep market knowledge

Leading industry partner ecosystem

and robust KOL engagement 

“Made-in-US” manufacturing

in New Jersey

Leadership & advisory

We’re led by a team of dynamic commercial and proven technical leaders.

Dhriti Sethi
Chief Executive Officer​ 
  • 10+ years of experience in industry-leading business development, portfolio design, commercial operations and M&As 
  • Formerly led portfolio strategy for Strides across global markets 

 

Read more
Joe Hendrickson
Head, Strategy and Corporate Development​ 
  • Seasoned pharmaceutical executive with 30+ years in global sterile injectables and hospital products
  • Served as former Head of Global Injectables at Mylan Inc. (Viatris) with prior leadership roles at Pfizer, Agila & Pharmacia 
Read more
Carl-Åke Carlsson​
Chief Commercial Advisor​ 
  • 15 years leading Xellia Pharmaceuticals as CEO
  • Grew the company to $300 million in annual sales​
Read more
Dr. Aleksandar Danilovski
Chief Scientific Advisor​
  • 30+ years in pharma with significant experience in developing specialty products, including 505b2 IV bags
  • Former Xellia Pharmaceuticals CSO, Barr Laboratories VP of European R&D, and PLIVA Pharmaceuticals board member 
Read more
Chris Eckerle​
Plant Site Head, New Jersey​
  • Drove end-to-end operations for vial and IV bag manufacturing, site expansions, and large-scale aseptic programs
  • Formerly at Xellia, AstraZeneca, Amylin, and Novo Nordisk 
Read more

Explore opportunities to grow with us

Join us to advance injectables that restore time and safety for those giving and receiving care.

Learn more